Olmesartan Related Products
Axios Research stands at the forefront of pharmaceutical reference standards ingenuity, providing high quality Olmesartan Reference Standards. These include both pharmacopeial and non-pharmacopeial Olmesartan impurities, metabolites, stable isotope products, and nitrosamines. Our Olmesartan impurity reference standards are essential for pharmaceutical research, aiding in product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They are also used in identifying unknown impurities and evaluating genotoxic potential. Our Olmesartan related products are meticulously characterized and come with a comprehensive Certificates of Analysis (COA) and analytical data that comply with regulatory standards.5-[4'-(Bromomethyl)[1,1'-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole
M.F.
M.W. 557.5
CAT# AR-O00893
CAS# 124750-51-2
Olmesartan-d4 (Olmesartan Medoxomil EP Impurity A-d4)
M.F.
M.W. 450.54
CAT# AR-O01215
CAS# 1420880-41-6
Olmesartan Medoxomil EP Impurity D (N2-Trityl Olmesartan Medoxomil)
M.F.
M.W. 800.92
CAT# AR-O01234
CAS# 1020157-01-0
4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one
M.F.
M.W. 194.23
CAT# AR-O01252
CAS# 849206-42-4